ePharma Summit discusses the future

Share this article:
The future of e-marketing will be in focus from Jan. 28- Jan. 30 when the some of the top names in e-marketing gather at Philadelphia's Ritz Carlton Hotel for the Institute for International Research's seventh annual ePharma Summit.
 
“2007 proved to be the year that pharmaceutical e-marketing reached the tipping point, where it became a key part of the brand marketing mix, and where budget allocations grew at unprecedented rates,” said Paul Ivans, president of Evolution Road and ePharma Summit chairman. “Now it's time for us to ramp up the scale of our e-marketing efforts to impact topline sales for our brands, and help massive numbers of consumers and physicians make better, more informed healthcare choices at the same time.”

Ivans will be among the featured speakers which include: AOL co-founder/Revolution Health CEO Steve Case; Google's health industry manager Khee Lee; Microsoft's Health Solutions VP Peter Neupert; Wyeth e-marketer Nancy Phelan; Shire e-marketing director Bob Harrell; Novartis head of
interactive marketing Stephen Calabrese; WEGO Health CEO Jack Barrette; aQuantive EVP Brad Aronson; and Sermo CEO Daniel Palestrant, MD. For more information, visit www.epharma
summit.com.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.